Peter Sklar

Statistics

Publications

Citations

3.6K

H-Index

Active since

2002

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Université Paris Cité

Orlando Immunology Center

Assistance Publique – Hôpitaux de Paris

Fundación Huésped

Peter Sklar is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in antiretroviral therapy, antiviral therapy, and pharmacotherapy.

ORCID

Publications per year

2002–2024

Publications

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

Jeffrey L. Lennox, Edwin DeJesus, Adriano Lazzarin et al. · The Lancet · 2009 · 620 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials

Joseph J. Eron, Benjamin Young, David A. Cooper et al. · The Lancet · 2010 · 314 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1–Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses

Jeffrey L. Lennox, Edwin DeJesus, Daniel S Berger et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2010 · 228 citations

Life Sciences, Pharmacology, Pharmacotherapy +17

Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients

Jürgen K. Rockstroh, Edwin DeJesus, Jeffrey L. Lennox et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2013 · 212 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trial

Joseph J. Eron, Jürgen K. Rockstroh, Jacques Reynes et al. · The Lancet Infectious Diseases · 2011 · 191 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +8

1–5 of 35